Trial Aimed at Helping Bladder Cancer Patients Choose Immunotherapy or Surgery – Immuno-Oncology News
Immuno-Oncology News |
Trial Aimed at Helping Bladder Cancer Patients Choose Immunotherapy or Surgery
Immuno-Oncology News Patients with bladder cancer often have to choose between surgical removal of their bladder or a three-year course of the immunotherapy Bacillus Calmette-Guérin (BCG), which most people know as the tuberculosis vaccine. The two options have never been … |
